SEZI — Senzime AB (publ) Share News
0.000.00%
- SEK551.04m
- SEK543.27m
- SEK104.02m
Sweden's Senzime Q3 sales rise on strong sensor demand
Brief: Senzime Reaffirms Target Of Positive Cash Flow In Q4 2026
Brief: Senzime Announces New Non-Dilutive Credit Facility Of SEK 35 Mln
Brief: Senzime Wins Additional Major US Hospital Network Contract
Brief: Senzime Awarded Exclusive 5-Year National Supply Contract
Sweden's Senzime Q2 sales fall on hospital contract delay
Brief: Senzime Q2 Adjusted Gross Margin 65.7%
Brief: Senzime, Philips Medical Systems Enter Development, Commercialization Partnership
Brief: Senzime Tetragraph System Receives Anvisa Approval For Sale In Brazil
Brief: Senzime Secures Contract With U.S. Hospital
Brief: Senzime Gets Additional FDA Class II 510(K) Clearance For Tetragraph System
Brief: Senzime's TetraGraph System Contracted On Three GPO Agreements In U.S.
Sweden's Senzime Q1 sales dip on weak US markets, strong krona
Brief: Senzime Q1 Operating Expenses SEK 35.562 Million
Brief: Senzime Wins Expanded Contract Within U.S. Hospital System
Brief: Senzime Secures Strategic Hospital Orders
Sweden's Senzime Q4 sales surge driven by hospital contracts, increased utilization rates
Brief: Senzime Q4 Sales Up At Sek 28.3 Million
Brief: Senzime Secures Credit Line Facility Of 50 Msek